Massive UK Biobank Study Finds Wine Drinkers Face Lower Mortality Risk Than Beer or Spirits Consumers

A landmark analysis of more than 340,000 adults in the United Kingdom has revealed a striking divergence in mortality risk based on the type of alcohol consumed, challenging the long-held notion that all alcoholic beverages carry equivalent health consequences. The study, drawing on UK Biobank (搜索)搜索该词条 data collected between 2006 and 2022, found that while heavy drinking unequivocally raises the risk of death, low-to-moderate wine consumption was associated with a significantly lower mortality risk—a pattern not observed for beer, cider, or spirits.

The findings, presented by researchers led by Zhangling Chen, MD, PhD, a professor at the Second Xiangya Hospital of Central South University (搜索)搜索该公司 in China, add nuance to an increasingly contentious debate over alcohol's health effects.

Heavy Drinking Confirmed as Clear Risk

Compared with individuals who never drank or drank only occasionally, those in the high-consumption group—defined as more than 40 grams of pure alcohol daily for men (approximately three standard drinks) and more than 20 grams for women (about 1.5 drinks)—were 24% more likely to die from any cause over an average follow-up of more than 13 years. Cancer mortality was 36% higher in this group, and cardiovascular mortality was 14% higher.

For reference, a 12-ounce can of beer, a 5-ounce glass of wine, and a 1.5-ounce shot of spirits each contain approximately 14 grams of pure alcohol.

The Beverage-Type Divide

At low and moderate consumption levels, a distinct pattern emerged. Spirits, beer, and cider were associated with a significantly greater risk of death, while similar levels of wine consumption were linked to a significantly lower risk.

The contrast was particularly pronounced in cardiovascular mortality. Moderate wine drinkers had a 21% lower risk of dying from cardiovascular disease (搜索)搜索该疾病 compared with never or occasional drinkers. In stark contrast, even low levels of spirits, beer, or cider consumption were associated with a 9% higher risk of cardiovascular death.

"Our findings help clarify previously mixed evidence on low to moderate alcohol consumption," Chen said. "These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed, but also on the type of beverage. Even low to moderate intake of spirits, beer or cider is linked to higher mortality, while low to moderate intake of wine may carry lower risk."

Why Wine Stands Apart

Several factors may explain the differential outcomes, according to the researchers. Red wine contains polyphenols and antioxidants, compounds that may confer cardiovascular benefits independent of alcohol itself. Equally important, drinking patterns and associated lifestyle behaviors appear to play a substantial role.

Wine is more often consumed with meals and tends to be favored by people with higher-quality diets and healthier behaviors overall. Spirits, beer, and cider, by contrast, are more commonly consumed outside of meals and were associated with poorer overall diet quality and other lifestyle risk factors.

"Taken together, these factors suggest that the type of alcohol, how it is consumed and the associated lifestyle behaviors all contribute to the observed differences in mortality risk," Chen said.

A Parallel Perspective from Harvard

The UK Biobank (搜索)搜索该词条 findings arrive alongside a separate comprehensive review from the Harvard T.H. Chan School of Public Health查看公司主页, which examined the broader landscape of alcohol and disease. That review, led by doctoral candidate Sinclair Carr and senior author Jürgen Rehm of the Centre for Addiction and Mental Health, found that more than 60 diseases in the WHO International Classification of Diseases are 100% attributable to alcohol consumption.

"There is no safe level for alcohol consumption with regard to cancer, period," Rehm stated. "Any amount of alcohol consumption increases your risk for several types of cancer."

However, the Harvard review also acknowledged the complexity of risk-benefit calculations. "Take breast cancer (搜索)搜索该疾病, which is the most studied cancer. Having one glass of wine every other day increases the risk of breast cancer but is also potentially protective for heart disease," Rehm explained. "We cannot say that there is risk-free drinking, but we also cannot say that low amounts are clearly harmful. Basically, the increased risk of one disease could be canceled out by the reduced risk of another."

Both research groups emphasized that alcohol type—whether red wine, beer, or whiskey—does not appear to matter for cancer risk. "Alcohol is alcohol is alcohol. There is no scientific evidence that type matters," Rehm said.

Reversibility and Individual Decision-Making

The Harvard review also highlighted evidence that some alcohol-related damage can be slowed or reversed by cutting down or quitting. Blood pressure, a major risk factor for heart disease, can be lowered through reduced consumption. Some brain shrinkage may be reversed upon cessation, and cancer risk may decrease after stopping drinking. However, certain chronic damage—particularly to the liver—may not be reversible, though reducing or stopping can slow disease progression.

Carr emphasized that the goal of such research is to empower individuals with accurate information. "People make their own decisions about drinking, and they should, but those decisions should be informed by a clear understanding of the potential health effects of drinking," Carr said. "For example, many do not know that alcohol increases the risk of several cancers."

Study Limitations

The UK Biobank (搜索)搜索该词条 study was observational, meaning it cannot establish causation. Alcohol intake was based on self-reported drinking habits at baseline, so changes over time were not captured. Additionally, UK Biobank participants tend to be healthier than the general population, which may limit the generalizability of the findings.

Despite these limitations, the large sample size and extended follow-up period provided substantial statistical power. Both research teams called for high-quality randomized trials—ideally testing the effects of reducing or stopping alcohol consumption—to further clarify the causal relationships at play.

"These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher," Chen cautioned.